We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First Human Clinical Trial Finds CRISPR Gene-edited Cells Safe and Durable for Cancer Therapy

News   Feb 06, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
First Human Clinical Trial Finds CRISPR Gene-edited Cells Safe and Durable for Cancer Therapy
 
 
 

RELATED ARTICLES

Genetic Profile Could Predict Chance of Type 2 Diabetes in Women With Gestational Diabetes

News

Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

READ MORE

Multi-center Study Explores Schizophrenia-linked Condition

News

A large-scale, multi-center study has provided insights into brain changes in those with a rare genetic disorder associated with schizophrenia.

READ MORE

Molecular Roadmap Fuels Fight Against Endometrial Cancer

News

Dozens of molecular steps that bring about endometrial cancer have been analyzed, helping form a clearer "molecular roadmap" of events that fuel the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE